Index -
P/E 25.53
EPS (ttm) 1.35
Insider Own 82.71%
Shs Outstand 236.79M
Perf Week 2.58%
Market Cap 8.19B
Forward P/E 10.74
EPS next Y 3.22
Insider Trans -0.02%
Shs Float 40.95M
Perf Month 7.39%
Income 321.57M
PEG -
EPS next Q 0.61
Inst Own 16.76%
Short Float 5.29%
Perf Quarter 28.25%
Sales 17.36B
P/S 0.47
EPS this Y 80.32%
Inst Trans -0.22%
Short Ratio 3.09
Perf Half Y 51.44%
Book/sh 14.07
P/B 2.46
EPS next Y 5.73%
ROA 3.37%
Short Interest 2.17M
Perf Year 55.53%
Cash/sh 3.09
P/C 11.20
EPS next 5Y -12.50%
ROE 10.42%
52W Range 19.96 - 34.37
Perf YTD 25.05%
Dividend Est. -
P/FCF 61.10
EPS past 5Y 6.37%
ROI 4.68%
52W High 0.65%
Beta 0.82
Dividend TTM -
Quick Ratio 0.89
Sales past 5Y 10.02%
Gross Margin 6.40%
52W Low 73.30%
ATR (14) 0.57
Dividend Ex-Date May 06, 2016
Current Ratio 1.68
EPS Y/Y TTM -55.98%
Oper. Margin 3.44%
RSI (14) 78.06
Volatility 0.87% 1.81%
Employees 61200
Debt/Eq 1.08
Sales Y/Y TTM -0.52%
Profit Margin 1.85%
Recom 2.25
Target Price 34.00
Option/Short Yes / Yes
LT Debt/Eq 1.06
EPS Q/Q 186.51%
Payout 0.00%
Rel Volume 0.50
Prev Close 34.31
Sales Surprise 1.18%
EPS Surprise 38.27%
Sales Q/Q 9.96%
Earnings Feb 26 BMO
Avg Volume 702.10K
Price 34.59
SMA20 4.64%
SMA50 14.90%
SMA200 32.49%
Trades
Volume 349,617
Change 0.82%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-13-23 Upgrade
BMO Capital Markets
Market Perform → Outperform
$26 → $28
Apr-28-23 Upgrade
BofA Securities
Neutral → Buy
$26
Apr-14-23 Resumed
BMO Capital Markets
Market Perform
$26
Mar-10-22 Upgrade
BMO Capital Markets
Market Perform → Outperform
$28 → $30
Feb-28-22 Resumed
BofA Securities
Neutral
$28
Feb-18-22 Upgrade
Stephens
Equal-Weight → Overweight
$30 → $35
Feb-08-21 Upgrade
Stephens
Equal-Weight → Overweight
$20 → $25
Jan-06-21 Upgrade
BofA Securities
Neutral → Buy
$25
Oct-30-20 Upgrade
Barclays
Equal Weight → Overweight
$20 → $22
Jun-29-20 Downgrade
BMO Capital Markets
Outperform → Market Perform
$21
Jun-29-20 Downgrade
Barclays
Overweight → Equal Weight
$20
Jun-03-20 Downgrade
Stephens
Overweight → Equal-Weight
May-11-20 Upgrade
Stephens
Equal-Weight → Overweight
$20 → $28
Jan-16-20 Downgrade
Stephens
Overweight → Equal-Weight
$35
Oct-25-19 Initiated
BofA/Merrill
Neutral
$32
Aug-20-19 Upgrade
BMO Capital Markets
Market Perform → Outperform
$31 → $36
Mar-05-19 Initiated
Stephens
Overweight
Jul-16-18 Initiated
Barclays
Overweight
$27
Mar-29-18 Initiated
Mizuho
Buy
$29
Nov-03-17 Initiated
Morgan Stanley
Equal-Weight
$30
Show Previous Ratings
Mar-27-24 11:30AM
Mar-21-24 09:40AM
Mar-20-24 09:40AM
Mar-15-24 09:50AM
Mar-14-24 09:15AM
09:40AM
Loading…
Mar-05-24 09:40AM
Mar-04-24 09:02PM
Feb-28-24 11:07AM
Feb-27-24 01:18PM
(Investor's Business Daily)
12:27PM
09:15AM
02:04AM
12:03AM
(Thomson Reuters StreetEvents)
Feb-26-24 11:27AM
08:18AM
07:55AM
Loading…
07:55AM
07:32AM
07:15AM
(Associated Press Finance)
07:04AM
07:00AM
Feb-25-24 02:01AM
Feb-21-24 09:06AM
Feb-10-24 02:34PM
Feb-05-24 12:45PM
Jan-25-24 03:37AM
Jan-23-24 04:30PM
Jan-15-24 11:14AM
Jan-03-24 02:32PM
(Investor's Business Daily)
Dec-18-23 11:06AM
Dec-14-23 09:40AM
02:02AM
Loading…
Nov-28-23 02:02AM
Nov-24-23 11:31AM
Nov-14-23 06:30AM
Nov-03-23 11:52AM
Oct-27-23 01:15PM
Oct-26-23 03:18PM
(Investor's Business Daily)
08:11AM
07:53AM
Oct-25-23 06:28PM
(Associated Press Finance)
06:08PM
Oct-23-23 11:00AM
Oct-13-23 09:40AM
Oct-11-23 06:15PM
Oct-10-23 04:30PM
Oct-02-23 12:03PM
Sep-27-23 05:13PM
09:16AM
Sep-20-23 09:42AM
Aug-25-23 11:31AM
Aug-13-23 09:46AM
Aug-07-23 11:34AM
Jul-31-23 05:18AM
Jul-27-23 12:31PM
10:25AM
Jul-26-23 05:25PM
05:00PM
Jul-21-23 06:55AM
Jul-14-23 09:40AM
Jul-12-23 09:16AM
(The Wall Street Journal)
07:03AM
07:03AM
Jul-11-23 04:58PM
Jun-30-23 07:51PM
Jun-21-23 08:00PM
May-28-23 09:18AM
May-26-23 11:31AM
May-12-23 11:42AM
May-02-23 11:40AM
09:40AM
Apr-27-23 07:42AM
Apr-26-23 08:00PM
06:11PM
04:52PM
Apr-24-23 07:58AM
Apr-06-23 06:52PM
Apr-04-23 04:48PM
09:10AM
Apr-03-23 08:00AM
(The Wall Street Journal)
Feb-16-23 09:00AM
Feb-09-23 01:04PM
11:37AM
Feb-08-23 05:00PM
Feb-02-23 09:44AM
Jan-27-23 01:19AM
Jan-17-23 10:49PM
Jan-11-23 09:40AM
Dec-29-22 08:48AM
Dec-15-22 12:55PM
Dec-09-22 11:24AM
09:40AM
Dec-01-22 08:36AM
Nov-25-22 11:31AM
Nov-07-22 04:57PM
Oct-28-22 06:24AM
Oct-27-22 06:56PM
(The Wall Street Journal)
12:26PM
11:08AM
Oct-26-22 04:30PM
Oct-20-22 10:38AM
Oct-17-22 02:58PM
(The Wall Street Journal)
Pilgrim's Pride Corp. engages in the production, processing, marketing, and distribution of fresh, frozen and value-added chicken and pork products to retailers, distributors, and foodservice operators. It operates through the following segments: U.S., U.K. and Europe, and Mexico. The company was founded by Lonnie A. Pilgrim and Aubrey Pilgrim on October 2, 1946, and is headquartered in Greeley, CO.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Sandri Fabio President and CEO Mar 14 '24 Sale 33.32 40,000 1,332,936 257,065 Mar 19 02:41 PM
Index RUT
P/E 87.21
EPS (ttm) 0.43
Insider Own 1.07%
Shs Outstand 48.84M
Perf Week -4.82%
Market Cap 1.84B
Forward P/E 42.51
EPS next Y 0.89
Insider Trans 288.12%
Shs Float 48.34M
Perf Month 15.36%
Income 21.35M
PEG 2.91
EPS next Q 0.02
Inst Own 105.58%
Short Float 11.24%
Perf Quarter 18.37%
Sales 322.42M
P/S 5.71
EPS this Y -47.87%
Inst Trans 1.94%
Short Ratio 7.47
Perf Half Y -6.84%
Book/sh 7.90
P/B 4.77
EPS next Y 68.44%
ROA 4.72%
Short Interest 5.43M
Perf Year -40.64%
Cash/sh 4.52
P/C 8.35
EPS next 5Y 30.00%
ROE 5.95%
52W Range 26.66 - 73.13
Perf YTD 20.79%
Dividend Est. -
P/FCF -
EPS past 5Y 31.51%
ROI 5.11%
52W High -48.45%
Beta 0.86
Dividend TTM -
Quick Ratio 5.08
Sales past 5Y 21.55%
Gross Margin 78.36%
52W Low 41.43%
ATR (14) 1.88
Dividend Ex-Date -
Current Ratio 5.62
EPS Y/Y TTM -45.63%
Oper. Margin 8.71%
RSI (14) 57.94
Volatility 4.75% 5.17%
Employees 1115
Debt/Eq 0.09
Sales Y/Y TTM 13.37%
Profit Margin 6.62%
Recom 2.08
Target Price 43.72
Option/Short Yes / Yes
LT Debt/Eq 0.08
EPS Q/Q 32.91%
Payout 0.00%
Rel Volume 0.58
Prev Close 36.00
Sales Surprise 0.43%
EPS Surprise -27.29%
Sales Q/Q 19.09%
Earnings Feb 26 AMC
Avg Volume 727.60K
Price 37.70
SMA20 3.81%
SMA50 15.85%
SMA200 -4.48%
Trades
Volume 421,952
Change 4.72%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-11-24 Upgrade
Stifel
Hold → Buy
$30 → $50
Dec-05-23 Downgrade
Needham
Buy → Hold
Dec-04-23 Initiated
Morgan Stanley
Equal-Weight
$35
Sep-15-23 Downgrade
The Benchmark Company
Buy → Hold
Aug-03-23 Downgrade
Canaccord Genuity
Buy → Hold
$77 → $48
Jun-07-23 Downgrade
William Blair
Outperform → Mkt Perform
Apr-17-23 Initiated
Piper Sandler
Neutral
$65
Feb-06-23 Downgrade
BTIG Research
Buy → Neutral
Dec-28-22 Reiterated
BTIG Research
Buy
$80 → $67
Dec-08-22 Initiated
Stifel
Hold
$60
Nov-07-22 Upgrade
Sidoti
Neutral → Buy
Oct-14-22 Resumed
Stephens
Overweight
$91
Oct-13-22 Initiated
Mizuho
Buy
$85
Apr-08-22 Initiated
Needham
Buy
$87
Mar-28-22 Upgrade
The Benchmark Company
Hold → Buy
$97
Mar-18-22 Upgrade
BTIG Research
Neutral → Buy
$98
Jul-09-21 Initiated
Oppenheimer
Perform
$150
Jan-19-21 Downgrade
The Benchmark Company
Buy → Hold
Oct-26-20 Downgrade
Sidoti
Buy → Neutral
Aug-31-20 Upgrade
Sidoti
Neutral → Buy
$58
Show Previous Ratings
Mar-20-24 04:22AM
Mar-18-24 07:00AM
Mar-12-24 10:30AM
07:00AM
Mar-06-24 07:00AM
10:58AM
Loading…
Feb-28-24 10:58AM
Feb-27-24 02:00PM
Feb-26-24 05:30PM
04:39PM
(Associated Press Finance)
04:34PM
04:01PM
Feb-19-24 07:00AM
Jan-27-24 01:03PM
Jan-23-24 07:00AM
Jan-12-24 06:49PM
07:00AM
Loading…
Jan-08-24 07:00AM
Dec-17-23 12:35PM
Dec-05-23 03:16AM
Dec-04-23 04:05PM
Nov-15-23 07:00AM
Nov-02-23 05:50PM
09:23AM
(Thomson Reuters StreetEvents)
Nov-01-23 06:30PM
05:56PM
04:17PM
(Associated Press Finance)
04:01PM
Oct-31-23 04:40PM
Oct-18-23 04:05PM
Oct-17-23 07:00AM
Oct-13-23 06:30PM
10:51AM
Loading…
Oct-10-23 10:51AM
Sep-19-23 11:51AM
Sep-15-23 09:32AM
Sep-14-23 12:53PM
07:00AM
Sep-08-23 11:38AM
Sep-07-23 05:00PM
Aug-18-23 10:40AM
Aug-17-23 06:48PM
Aug-09-23 07:00AM
Aug-07-23 07:00AM
05:00AM
Aug-03-23 07:18PM
Aug-02-23 05:25PM
04:21PM
04:01PM
Jul-19-23 07:00AM
Jun-21-23 08:00PM
Jun-13-23 08:00AM
May-26-23 06:00AM
May-17-23 10:10AM
May-09-23 01:48PM
May-04-23 07:00AM
May-03-23 05:35PM
04:29PM
04:01PM
Apr-27-23 10:02AM
Apr-26-23 08:00PM
10:02AM
Apr-23-23 08:25AM
Apr-19-23 07:00AM
Apr-07-23 11:44AM
Apr-04-23 06:00PM
Mar-29-23 06:00PM
07:00AM
Mar-23-23 06:00PM
Mar-15-23 05:50PM
Mar-13-23 08:48AM
Mar-09-23 05:25AM
Feb-23-23 05:12AM
Feb-21-23 05:15PM
04:01PM
Feb-13-23 05:50PM
Feb-07-23 07:00AM
Feb-03-23 05:50PM
01:58PM
09:00AM
Jan-31-23 09:25AM
Jan-25-23 06:00PM
Jan-24-23 03:26PM
Jan-17-23 06:00PM
Jan-11-23 07:00AM
Jan-10-23 06:41AM
Jan-09-23 07:00AM
Jan-06-23 09:13PM
01:52PM
Dec-30-22 07:17AM
Dec-20-22 08:56AM
Dec-19-22 08:15AM
Dec-13-22 11:01AM
Nov-28-22 01:18PM
Nov-17-22 07:00AM
Nov-13-22 09:28AM
Nov-11-22 08:38AM
Nov-02-22 05:25PM
04:01PM
Oct-29-22 10:49AM
Oct-24-22 12:45PM
Oct-19-22 07:00AM
Oct-12-22 07:00AM
STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
WEISNER AIMEE S Director Mar 14 '24 Buy 38.11 1,750 66,692 10,864 Mar 14 05:23 PM Williams Patrick F. Chief Financial Officer Mar 07 '24 Option Exercise 0.00 2,614 0 45,475 Mar 11 06:06 AM BROADWOOD PARTNERS, L.P. 10% Owner Jan 08 '24 Buy 27.11 4,042 109,570 10,768,430 Jan 10 05:44 PM BROADWOOD PARTNERS, L.P. 10% Owner Jan 05 '24 Buy 28.48 156,734 4,463,231 10,764,388 Jan 05 07:07 PM BROADWOOD PARTNERS, L.P. 10% Owner Jan 04 '24 Buy 28.91 63,246 1,828,183 10,607,654 Jan 05 07:07 PM BROADWOOD PARTNERS, L.P. 10% Owner Jan 03 '24 Buy 28.93 6,573 190,144 10,544,408 Jan 05 07:07 PM Zhou Lilian Yansheng Director Dec 06 '23 Buy 30.74 850 26,129 2,327 Dec 06 04:11 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 30 '23 Buy 31.42 177,707 5,583,678 10,537,835 Nov 30 07:08 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 29 '23 Buy 31.39 160,300 5,031,358 10,360,128 Nov 30 07:08 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 28 '23 Buy 31.85 96,984 3,088,794 10,199,828 Nov 30 07:08 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 13 '23 Buy 33.04 507 16,749 10,102,844 Nov 14 07:13 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 10 '23 Buy 32.73 34,320 1,123,383 10,102,337 Nov 14 07:13 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 09 '23 Buy 33.09 140,000 4,632,581 10,068,017 Nov 09 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 08 '23 Buy 33.71 139,409 4,699,073 9,928,017 Nov 09 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 07 '23 Buy 34.03 9,731 331,127 9,788,608 Nov 09 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 06 '23 Buy 34.16 164,607 5,623,518 9,778,877 Nov 06 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 03 '23 Buy 36.06 520 18,753 9,614,270 Nov 06 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 02 '23 Buy 35.79 144,027 5,155,243 9,613,750 Nov 06 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Oct 06 '23 Buy 37.62 75,299 2,832,417 9,469,723 Oct 06 07:43 PM BROADWOOD PARTNERS, L.P. 10% Owner Oct 05 '23 Buy 37.92 97,474 3,696,399 9,394,424 Oct 06 07:43 PM BROADWOOD PARTNERS, L.P. 10% Owner Oct 04 '23 Buy 37.93 32,523 1,233,649 9,296,950 Oct 06 07:43 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 21 '23 Buy 39.62 154,814 6,133,467 9,264,427 Sep 21 08:31 PM Lin Elizabeth Yeu Director Sep 21 '23 Buy 40.00 2,500 100,000 2,855 Sep 22 07:18 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 20 '23 Buy 40.67 132,079 5,372,274 9,109,613 Sep 21 08:31 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 19 '23 Buy 40.89 4,490 183,613 8,977,534 Sep 21 08:31 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 07 '23 Buy 41.26 60,874 2,511,722 8,973,044 Sep 07 07:00 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 06 '23 Buy 41.43 108,944 4,513,735 8,912,170 Sep 07 07:00 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 05 '23 Buy 41.87 20,144 843,455 8,803,226 Sep 07 07:00 PM Williams Patrick F. Chief Financial Officer Aug 10 '23 Option Exercise 0.00 5,122 0 45,400 Aug 11 06:01 PM WEISNER AIMEE S Director Aug 07 '23 Buy 48.72 2,000 97,440 5,417 Aug 07 04:16 PM Kliman Gilbert H Director Jun 15 '23 Option Exercise 0.00 3,417 0 9,656 Jun 16 08:39 PM WEISNER AIMEE S Director Jun 15 '23 Option Exercise 0.00 3,417 0 3,417 Jun 16 08:37 PM Yu K Peony Director Jun 15 '23 Option Exercise 0.00 1,709 0 2,786 Jun 16 08:35 PM FARRELL STEPHEN C Director Jun 15 '23 Option Exercise 0.00 1,709 0 8,276 Jun 16 08:41 PM Williams Patrick F. Chief Financial Officer Jun 06 '23 Option Exercise 0.00 5,121 0 47,387 Jun 07 04:53 PM Michna Magda Chief Clinical, Regulatory, May 08 '23 Option Exercise 0.00 14,047 0 14,047 May 09 05:26 PM Foust Warren Chief Operating Officer May 08 '23 Option Exercise 0.00 20,331 0 20,331 May 09 05:24 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite